If the recent recession highlighted anything to firms in all sectors, it was how important it is for them to focus on...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,250 news
and
4,718 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
From biofuel to genetic discrimination, it's all summarized here....
A former insider comments on shifting leadership in the pharmaceutical industry.
Should a branded biotech get 5 years or 12 years of protection from generic competition?
Talecris Biotherapeutics (TLCR) plans to go public this week. The biotech company is a maker of plasma-derived protein...
The new administration in Washington is expected to lift restrictions on federal research for stem cells, and opponents...
Live oral rotavirus vaccines have proven to be generally safe and effective to prevent severe dehydrating diarrhea...
When it comes to the pharmaceutical industry, few would argue that the biggest issue which drives success in the sector...
Vaccine development is again enjoying a renaissance, buoyed in part by the need to meet the challenge of a global...
Biotech giant Amgen finally won FDA approval for an osteoporosis drug that Wall Street types predict will be the...
According to this article in outsourcing-pharma.com Pfizer has teamed up with Private Access Team to boost trial...
As a growing number of industry authorities confirm that they only intend to accept documents for approval in...
With activist investor Carl Icahn pushing to split Biogen Idec into two companies, analysts think the biotech could...
Why is the Chinese market poised to take over Pharmacovigilance? Jean Christophe Delumeau, Head of Pharmacovigilance...
In most spheres of business, the success of companies strongly depends on the data they possess. However, the...
Pharma IQ's Helen Winsor investigates the current state of Paediatric Plans and asks if the new European Paediatric...
Biotech/Pharma Stocks Sector Close-Up; Exelixis, Inc. (NasdaqGS: EXEL) and Peregrine Pharmaceuticals, Inc.
AstraZeneca, the Anglo-Swedish pharmaceuticals group, is looking at developing lower-cost versions of its rivals’...
The team in charge of the blockbuster antipsychotic Seroquel had one mission: make the multibillion-dollar seller even...
In the next five years the global market for anti-infective drugs is projected to increase by over 50%, there is great...
The UK Biobank has smashed its initial target of filing the DNA of 500,000 adults aged 40-69, in what is seen as being...
Physicians have an innate tendency to trust in governing medical entities like American Medical Association (AMA), Food...
For more than three decades, scientists have dreamed of unleashing one of nature’s most powerful inventions, the human...
Claiming ownership over a brand or item is often essential to the success of a company. According to Chris Barry, an...
New York, NY and Philadelphia, PA – Pharma IQ, a division of IQPC, announces the US Department of Homeland Security,...
Top Sources: Business of Biotechnology
- investorideas.com
- bioedgeconsulting.com
- Biotech Blog
- bloomberg.com
- News
- youtube.com
- contrarianprofits.com
- Forbes.com
- industry.bnet.com
- Health Beat
account